Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 10 | 2018 | 13 | 6.40 | Why? |
| Parkinson Disease | 27 | 2020 | 1414 | 5.93 | Why? |
| Cellular Reprogramming | 4 | 2016 | 117 | 2.40 | Why? |
| Induced Pluripotent Stem Cells | 5 | 2018 | 584 | 1.83 | Why? |
| Genetic Association Studies | 4 | 2018 | 559 | 1.79 | Why? |
| Dopaminergic Neurons | 4 | 2017 | 59 | 1.53 | Why? |
| Essential Tremor | 2 | 2018 | 19 | 1.43 | Why? |
| Mitochondria | 4 | 2018 | 857 | 1.34 | Why? |
| Protein Kinases | 2 | 2017 | 93 | 1.17 | Why? |
| Parkinson Disease, Secondary | 2 | 2020 | 15 | 1.00 | Why? |
| Genome-Wide Association Study | 4 | 2018 | 1648 | 0.99 | Why? |
| Amyloid beta-Protein Precursor | 2 | 2017 | 30 | 0.88 | Why? |
| Biomedical Research | 4 | 2020 | 5270 | 0.79 | Why? |
| Blepharospasm | 1 | 2018 | 5 | 0.78 | Why? |
| F-Box Proteins | 1 | 2018 | 13 | 0.78 | Why? |
| CD36 Antigens | 1 | 2018 | 44 | 0.76 | Why? |
| Laboratory Personnel | 1 | 2020 | 126 | 0.74 | Why? |
| Genetic Predisposition to Disease | 3 | 2018 | 4027 | 0.74 | Why? |
| Proton Ionophores | 1 | 2017 | 2 | 0.73 | Why? |
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2017 | 4 | 0.73 | Why? |
| Dyslexia, Acquired | 1 | 2017 | 1 | 0.73 | Why? |
| Lysosomal Storage Diseases | 1 | 2018 | 30 | 0.72 | Why? |
| Superoxides | 1 | 2017 | 36 | 0.72 | Why? |
| Neurosciences | 1 | 2020 | 148 | 0.72 | Why? |
| Ubiquitin-Protein Ligases | 2 | 2017 | 249 | 0.72 | Why? |
| DNA Repeat Expansion | 1 | 2017 | 5 | 0.72 | Why? |
| Movement Disorders | 1 | 2021 | 186 | 0.72 | Why? |
| Polymorphism, Single Nucleotide | 8 | 2018 | 3607 | 0.72 | Why? |
| alpha-Synuclein | 1 | 2018 | 71 | 0.71 | Why? |
| Sequestosome-1 Protein | 1 | 2017 | 8 | 0.71 | Why? |
| Mice, Inbred NOD | 5 | 2017 | 134 | 0.70 | Why? |
| Vitamin B 6 | 1 | 2017 | 18 | 0.70 | Why? |
| C9orf72 Protein | 1 | 2017 | 27 | 0.69 | Why? |
| Multilingualism | 1 | 2017 | 32 | 0.69 | Why? |
| Functional Laterality | 1 | 2017 | 57 | 0.69 | Why? |
| Facial Paralysis | 1 | 2021 | 231 | 0.69 | Why? |
| Karyotype | 4 | 2016 | 16 | 0.69 | Why? |
| Mice, SCID | 5 | 2017 | 225 | 0.68 | Why? |
| Cognitive Dysfunction | 3 | 2018 | 1389 | 0.68 | Why? |
| Dopamine | 2 | 2017 | 123 | 0.67 | Why? |
| Membrane Potential, Mitochondrial | 1 | 2017 | 102 | 0.67 | Why? |
| Teratoma | 4 | 2016 | 25 | 0.67 | Why? |
| Drosophila Proteins | 1 | 2017 | 67 | 0.66 | Why? |
| Neural Pathways | 1 | 2017 | 155 | 0.63 | Why? |
| Mitochondrial Proteins | 1 | 2017 | 152 | 0.63 | Why? |
| Nerve Net | 1 | 2017 | 118 | 0.62 | Why? |
| Antiparkinson Agents | 1 | 2017 | 125 | 0.62 | Why? |
| Vitamin B 12 | 1 | 2017 | 132 | 0.61 | Why? |
| Microscopy, Fluorescence | 4 | 2016 | 335 | 0.61 | Why? |
| Mutation | 6 | 2018 | 12376 | 0.60 | Why? |
| Folic Acid | 1 | 2017 | 172 | 0.60 | Why? |
| Neuropsychological Tests | 5 | 2018 | 954 | 0.59 | Why? |
| Genetic Loci | 1 | 2017 | 439 | 0.58 | Why? |
| DNA Mutational Analysis | 4 | 2016 | 581 | 0.54 | Why? |
| Genetic Testing | 1 | 2017 | 395 | 0.52 | Why? |
| Genetic Variation | 2 | 2018 | 3919 | 0.52 | Why? |
| Genotype | 8 | 2018 | 4697 | 0.52 | Why? |
| Alzheimer Disease | 3 | 2018 | 1020 | 0.50 | Why? |
| Sleep Wake Disorders | 2 | 2017 | 1463 | 0.50 | Why? |
| Drug Prescriptions | 1 | 2021 | 1062 | 0.47 | Why? |
| Olfaction Disorders | 3 | 2020 | 3704 | 0.47 | Why? |
| Transcription Factors | 5 | 2018 | 784 | 0.46 | Why? |
| Neurodegenerative Diseases | 1 | 2017 | 469 | 0.44 | Why? |
| Tremor | 2 | 2018 | 89 | 0.43 | Why? |
| Cell Differentiation | 4 | 2016 | 1338 | 0.42 | Why? |
| Psychotic Disorders | 2 | 2017 | 924 | 0.40 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2017 | 2134 | 0.40 | Why? |
| Research Personnel | 1 | 2020 | 1037 | 0.40 | Why? |
| Polysomnography | 1 | 2011 | 296 | 0.40 | Why? |
| Pain | 1 | 2017 | 1084 | 0.38 | Why? |
| Base Sequence | 4 | 2016 | 3581 | 0.36 | Why? |
| Neurology | 1 | 2020 | 1613 | 0.36 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.36 | Why? |
| Brain | 5 | 2018 | 5133 | 0.36 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.34 | Why? |
| Outpatients | 1 | 2020 | 3417 | 0.34 | Why? |
| Heterozygote | 2 | 2018 | 249 | 0.33 | Why? |
| Leukocytes, Mononuclear | 4 | 2016 | 2115 | 0.33 | Why? |
| Membrane Proteins | 1 | 2017 | 1733 | 0.32 | Why? |
| Apoptosis | 1 | 2017 | 2335 | 0.32 | Why? |
| Age of Onset | 2 | 2018 | 557 | 0.30 | Why? |
| Whole Exome Sequencing | 2 | 2018 | 437 | 0.29 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 1510 | 0.29 | Why? |
| Facial Muscles | 1 | 2003 | 33 | 0.27 | Why? |
| Humans | 52 | 2021 | 930598 | 0.26 | Why? |
| Cell Line | 5 | 2016 | 12040 | 0.26 | Why? |
| HeLa Cells | 2 | 2017 | 1303 | 0.26 | Why? |
| Diffusion Tensor Imaging | 3 | 2018 | 125 | 0.25 | Why? |
| Postural Balance | 3 | 2018 | 144 | 0.25 | Why? |
| Nervous System Diseases | 1 | 2021 | 4092 | 0.24 | Why? |
| Mice | 7 | 2017 | 21357 | 0.23 | Why? |
| Alleles | 2 | 2018 | 1557 | 0.22 | Why? |
| Gait | 2 | 2018 | 137 | 0.21 | Why? |
| Hydrogen Peroxide | 2 | 2017 | 680 | 0.21 | Why? |
| Meta-Analysis as Topic | 2 | 2018 | 1289 | 0.21 | Why? |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2003 | 314 | 0.20 | Why? |
| Protein Aggregation, Pathological | 1 | 2018 | 36 | 0.19 | Why? |
| Globus Pallidus | 1 | 2018 | 34 | 0.19 | Why? |
| Antimycin A | 1 | 2017 | 5 | 0.18 | Why? |
| Endothelin-1 | 1 | 2018 | 69 | 0.18 | Why? |
| Ataxia Telangiectasia Mutated Proteins | 1 | 2017 | 48 | 0.18 | Why? |
| Homocystine | 1 | 2017 | 1 | 0.18 | Why? |
| Proto-Oncogene Proteins c-mdm2 | 1 | 2017 | 35 | 0.18 | Why? |
| Rotenone | 1 | 2017 | 7 | 0.18 | Why? |
| Mesencephalon | 1 | 2017 | 12 | 0.18 | Why? |
| Mitochondrial Membranes | 1 | 2017 | 12 | 0.18 | Why? |
| Nerve Degeneration | 1 | 2017 | 73 | 0.18 | Why? |
| Sensation Disorders | 1 | 2018 | 103 | 0.17 | Why? |
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2017 | 28 | 0.17 | Why? |
| Multiple System Atrophy | 1 | 2018 | 66 | 0.17 | Why? |
| Drosophila | 1 | 2017 | 55 | 0.17 | Why? |
| Synaptic Transmission | 1 | 2017 | 46 | 0.17 | Why? |
| Neuroprotection | 1 | 2017 | 62 | 0.17 | Why? |
| Cytochromes c | 1 | 2017 | 44 | 0.17 | Why? |
| White Matter | 2 | 2018 | 369 | 0.17 | Why? |
| Vitamin B Complex | 1 | 2017 | 49 | 0.17 | Why? |
| tau Proteins | 1 | 2018 | 162 | 0.17 | Why? |
| Case-Control Studies | 4 | 2018 | 17671 | 0.17 | Why? |
| Male | 25 | 2020 | 367725 | 0.16 | Why? |
| Far East | 1 | 2017 | 125 | 0.16 | Why? |
| Phosphorylation | 2 | 2017 | 1060 | 0.16 | Why? |
| Motor Neuron Disease | 1 | 2017 | 45 | 0.16 | Why? |
| Animals | 10 | 2018 | 78931 | 0.16 | Why? |
| Causality | 1 | 2020 | 857 | 0.16 | Why? |
| Middle Aged | 19 | 2020 | 270681 | 0.16 | Why? |
| Sendai virus | 1 | 2016 | 111 | 0.16 | Why? |
| Reading | 1 | 2017 | 80 | 0.16 | Why? |
| Homozygote | 1 | 2017 | 230 | 0.16 | Why? |
| Proteolysis | 2 | 2017 | 751 | 0.16 | Why? |
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 230 | 0.16 | Why? |
| Neural Stem Cells | 1 | 2017 | 135 | 0.16 | Why? |
| Loss of Function Mutation | 1 | 2018 | 244 | 0.16 | Why? |
| Phenotype | 2 | 2018 | 4037 | 0.16 | Why? |
| Prefrontal Cortex | 1 | 2017 | 151 | 0.15 | Why? |
| Locomotion | 1 | 2017 | 130 | 0.15 | Why? |
| Protein Transport | 1 | 2017 | 487 | 0.15 | Why? |
| Triglycerides | 1 | 2018 | 478 | 0.15 | Why? |
| Risk | 2 | 2018 | 5288 | 0.15 | Why? |
| DNA Damage | 1 | 2017 | 285 | 0.15 | Why? |
| Interferon-alpha | 1 | 2003 | 1442 | 0.15 | Why? |
| Uric Acid | 1 | 2018 | 285 | 0.14 | Why? |
| Microscopy, Electron, Transmission | 1 | 2017 | 605 | 0.14 | Why? |
| Blotting, Western | 1 | 2017 | 863 | 0.14 | Why? |
| Tyrosine 3-Monooxygenase | 1 | 2013 | 32 | 0.14 | Why? |
| Olfactory Mucosa | 1 | 2017 | 372 | 0.14 | Why? |
| Parkinsonian Disorders | 1 | 2016 | 118 | 0.14 | Why? |
| Oxidative Stress | 2 | 2017 | 2050 | 0.14 | Why? |
| Mental Disorders | 1 | 2017 | 6742 | 0.14 | Why? |
| Epidemiologic Methods | 1 | 2018 | 392 | 0.13 | Why? |
| Free Radicals | 1 | 2013 | 55 | 0.13 | Why? |
| Female | 22 | 2020 | 380317 | 0.13 | Why? |
| Cell Culture Techniques | 1 | 2018 | 704 | 0.13 | Why? |
| Stroke | 1 | 2017 | 8839 | 0.13 | Why? |
| Haplotypes | 1 | 2017 | 853 | 0.13 | Why? |
| Mental Health | 1 | 2020 | 15770 | 0.13 | Why? |
| Mice, Transgenic | 2 | 2017 | 2739 | 0.13 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.13 | Why? |
| Gene Frequency | 1 | 2018 | 1210 | 0.12 | Why? |
| Depression | 1 | 2017 | 14116 | 0.12 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.12 | Why? |
| Aged | 16 | 2018 | 215776 | 0.12 | Why? |
| Stem Cell Transplantation | 1 | 2017 | 531 | 0.11 | Why? |
| REM Sleep Behavior Disorder | 1 | 2011 | 24 | 0.11 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.11 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.11 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.11 | Why? |
| Restless Legs Syndrome | 1 | 2011 | 53 | 0.11 | Why? |
| Levodopa | 1 | 2011 | 87 | 0.11 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2017 | 665 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Lipids | 1 | 2017 | 1079 | 0.10 | Why? |
| Autophagy | 1 | 2017 | 960 | 0.10 | Why? |
| Neuroimaging | 1 | 2017 | 1106 | 0.10 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.10 | Why? |
| Genetic Vectors | 1 | 2016 | 1600 | 0.10 | Why? |
| Movement | 1 | 2011 | 232 | 0.10 | Why? |
| Telemedicine | 1 | 2021 | 25032 | 0.10 | Why? |
| Cells, Cultured | 2 | 2017 | 5835 | 0.09 | Why? |
| Cell Line, Tumor | 1 | 2017 | 3608 | 0.09 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.09 | Why? |
| Molecular Targeted Therapy | 1 | 2017 | 1579 | 0.09 | Why? |
| Antineoplastic Agents | 1 | 2003 | 3550 | 0.08 | Why? |
| Protein Kinase Inhibitors | 1 | 2017 | 1585 | 0.08 | Why? |
| HEK293 Cells | 2 | 2017 | 8394 | 0.08 | Why? |
| Respiration | 1 | 2011 | 729 | 0.08 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.08 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.07 | Why? |
| Patient Safety | 1 | 2021 | 4885 | 0.07 | Why? |
| Drug Design | 1 | 2017 | 2627 | 0.07 | Why? |
| Adult | 7 | 2020 | 244371 | 0.07 | Why? |
| Magnetic Resonance Imaging | 2 | 2016 | 6551 | 0.07 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.07 | Why? |
| Sex Characteristics | 1 | 2011 | 1120 | 0.06 | Why? |
| Disease Models, Animal | 2 | 2018 | 10998 | 0.06 | Why? |
| Electromyography | 1 | 2003 | 278 | 0.06 | Why? |
| Clinical Trials as Topic | 1 | 2021 | 7330 | 0.05 | Why? |
| Time | 1 | 2003 | 631 | 0.05 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.05 | Why? |
| Gene Expression Regulation | 1 | 2013 | 4020 | 0.05 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.05 | Why? |
| Population Surveillance | 1 | 2017 | 4967 | 0.05 | Why? |
| Acetyltransferases | 1 | 2018 | 30 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Walking Speed | 1 | 2018 | 77 | 0.04 | Why? |
| NIH 3T3 Cells | 1 | 2017 | 147 | 0.04 | Why? |
| Cell Division | 1 | 2017 | 136 | 0.04 | Why? |
| Gait Disorders, Neurologic | 1 | 2018 | 64 | 0.04 | Why? |
| Neurogenesis | 1 | 2017 | 64 | 0.04 | Why? |
| Singapore | 2 | 2018 | 3641 | 0.04 | Why? |
| United Kingdom | 1 | 2018 | 18046 | 0.04 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.04 | Why? |
| Electroencephalography | 1 | 2003 | 1242 | 0.04 | Why? |
| Cell Cycle Proteins | 1 | 2017 | 297 | 0.04 | Why? |
| Doxorubicin | 1 | 2017 | 313 | 0.04 | Why? |
| Respiratory Insufficiency | 1 | 2017 | 7301 | 0.04 | Why? |
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 317 | 0.04 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2017 | 310 | 0.04 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2018 | 1008 | 0.04 | Why? |
| DNA-Binding Proteins | 1 | 2017 | 469 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.03 | Why? |
| Recombinant Proteins | 1 | 2003 | 3786 | 0.03 | Why? |
| Psychiatric Status Rating Scales | 1 | 2018 | 1340 | 0.03 | Why? |
| Amyotrophic Lateral Sclerosis | 1 | 2017 | 398 | 0.03 | Why? |
| Imaging, Three-Dimensional | 1 | 2016 | 680 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Risk Factors | 2 | 2017 | 71621 | 0.03 | Why? |
| China | 1 | 2017 | 50654 | 0.03 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.03 | Why? |
| Physical Therapy Modalities | 1 | 2018 | 1090 | 0.02 | Why? |
| Cohort Studies | 3 | 2018 | 36005 | 0.02 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2003 | 7220 | 0.02 | Why? |
| Demography | 1 | 2016 | 1660 | 0.02 | Why? |
| Image Processing, Computer-Assisted | 1 | 2017 | 1383 | 0.02 | Why? |
| Smell | 1 | 2017 | 1851 | 0.02 | Why? |
| Surveys and Questionnaires | 2 | 2016 | 43792 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Health Surveys | 1 | 2018 | 2841 | 0.02 | Why? |
| Dementia | 1 | 2017 | 1861 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.02 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2018 | 48226 | 0.01 | Why? |
| Retrospective Studies | 1 | 2017 | 105322 | 0.00 | Why? |